Fig. 6From: Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabiesThe determination of the PRV neutralizing antibodies. PRV neutralizing antibodies were measured in sera by plaque reduction neutralization test (PRNT). Data were shown as the mean ± SD. **P < 0.01Back to article page